Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 6/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL344909 | 1.00 | ALDH1A1 (0.39) | ALDH1A1LMNAMEN1KMT2ATSHR | |
| SCHEMBL2532522 | 1.00 | ALDH1A1 (0.39) | ALDH1A1LMNAMEN1KMT2ATSHR | |
| SCHEMBL2528683 | 1.00 | ALDH1A1 (0.39) | ALDH1A1LMNAMEN1KMT2ATSHR | |
| SCHEMBL1002493 | 0.97 | ALDH1A1 (0.38) | ALDH1A1LMNAMEN1KMT2ATSHR | |
| SCHEMBL195733 | 0.97 | — | — | |
| SCHEMBL17800988 | 0.95 | ALDH1A1 (0.36) | ALDH1A1LMNAMEN1KMT2ATSHR | |
| SCHEMBL8782077 | 0.95 | ALDH1A1 (0.38) | ALDH1A1LMNAMEN1KMT2ATSHR | |
| Propylene Glycol SCHEMBL7581354 | 0.91 | TDP1 (0.43) | ALDH1A1LMNAMEN1KMT2ATSHR | |
| SCHEMBL2949576 | 0.90 | MEN1 (0.41) | ALDH1A1LMNAMEN1KMT2ATSHR | |
| SCHEMBL2964622 | 0.90 | MEN1 (0.41) | ALDH1A1LMNAMEN1KMT2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4015592-B1 | CURABLE CONDENSATION COMPOUNDS ON THE BASIS OF ALKOXY-FUNCTIONAL POLYSILOXANES | EVONIK OPERATIONS GMBH (DE) | 2026-03-18 | — | — | EP | claimed |
| US-12460081-B2 | Curable condensation compounds based on alkoxy-functional polysiloxanes | EVONIK OPERATIONS GMBH (DE) | 2025-11-04 | — | — | US | claimed |
| US-12152109-B2 | Curable condensation compounds based on alkoxy-functional polysiloxanes | EVONIK OPERATIONS GMBH (DE) | 2024-11-26 | — | — | US | claimed |
| EP-4186954-A1 | CURABLE CONDENSATION COMPOUNDS BASED ON ALKOXY-FUNCTIONAL POLYSILOXANES | Evonik Operations GmbH (DE) | 2023-05-31 | — | — | EP | claimed |
| US-20230159756-A1 | Curable condensation compounds based on alkoxy-functional polysiloxanes | EVONIK OPERATIONS GMBH (DE) | 2023-05-25 | — | — | US | claimed |
| EP-4015592-A2 | CURABLE CONDENSATION COMPOUNDS ON THE BASIS OF ALKOXY-FUNCTIONAL POLYSILOXANES | Evonik Operations GmbH (DE) | 2022-06-22 | — | — | EP | claimed |
| EP-4011992-A1 | CURABLE CONDENSATION COMPOUNDS ON THE BASIS OF ALKOXY-FUNCTIONAL POLYSILOXANES | Evonik Operations GmbH (DE) | 2022-06-15 | — | — | EP | claimed |
| US-20220177652-A1 | Curable condensation compounds based on alkoxy-functional polysiloxanes | EVONIK OPERATIONS GMBH (DE) | 2022-06-09 | — | — | US | claimed |
| EP-0802236-B1 | CURABLE POLYMETHYLSILSESQUIOXANE COMPOSITION | DOW CORNING ASIA LTD (JP) | 2002-04-10 | — | — | EP | claimed |
| US-12460081-B2 | Curable condensation compounds based on alkoxy-functional polysiloxanes | EVONIK OPERATIONS GMBH (DE) | 2025-11-04 | — | — | US | disclosed |
| US-12152109-B2 | Curable condensation compounds based on alkoxy-functional polysiloxanes | EVONIK OPERATIONS GMBH (DE) | 2024-11-26 | — | — | US | disclosed |
| EP-4186954-A1 | CURABLE CONDENSATION COMPOUNDS BASED ON ALKOXY-FUNCTIONAL POLYSILOXANES | Evonik Operations GmbH (DE) | 2023-05-31 | — | — | EP | disclosed |
| US-20230159756-A1 | Curable condensation compounds based on alkoxy-functional polysiloxanes | EVONIK OPERATIONS GMBH (DE) | 2023-05-25 | — | — | US | disclosed |
| EP-4015592-A2 | CURABLE CONDENSATION COMPOUNDS ON THE BASIS OF ALKOXY-FUNCTIONAL POLYSILOXANES | Evonik Operations GmbH (DE) | 2022-06-22 | — | — | EP | disclosed |
| US-9353225-B2 | Compounds having guanidine groups and containing semi-organic silicon groups | EVONIK DEGUSSA GMBH (DE) | 2016-05-31 | — | — | US | disclosed |
| WO-2015039838-A1 | ROOM TEMPERATURE-CURING SILICONE-POLYESTER BINDER | EVONIK INDUSTRIES AG (DE) | 2015-03-26 | — | — | WO | disclosed |
| WO-2015039837-A1 | HYDROXYL GROUP-CONTAINING SILICON-POLYESTER-ACRYLATE BINDERS | EVONIK INDUSTRIES AG (DE) | 2015-03-26 | — | — | WO | disclosed |
| US-20150057412-A1 | COMPOUNDS HAVING GUANIDINE GROUPS AND CONTAINING SEMI-ORGANIC SILICON GROUPS | EVONIK DEGUSSA GMBH (DE) | 2015-02-26 | — | — | US | disclosed |
| EP-0600718-B1 | Secondary battery | CANON KK (JP) | 2000-04-26 | — | — | EP | disclosed |
| EP-0600718-A2 | Secondary battery | CANON KABUSHIKI KAISHA (JP) | 1994-06-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150057412-A1 | COMPOUNDS HAVING GUANIDINE GROUPS AND CONTAINING SEMI-ORGANIC SILICON GROUPS | ALKBH5, ALKBH2, SMYD2 | ALDH1A1 1216/4885LMNA 1186/4885MEN1 3492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.